Eagle Health Investments LP Axonics, Inc. Transaction History

Eagle Health Investments LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$57.96 - $78.12 $8.46 Million - $11.4 Million	-145,905 Reduced 56.89%	110,560 $7.79 Million
Q4 2021 Feb 10, 2022	BUY	$50.01 - $73.35 $3.31 Million - $4.85 Million	66,100 Added 34.72%	256,465 $14.4 Million
Q3 2021 Oct 20, 2021	SELL	$59.21 - $78.66 $2.62 Million - $3.48 Million	-44,200 Reduced 18.84%	190,365 $12.4 Million
Q2 2021 Jul 19, 2021	BUY	$51.39 - $66.9 $2.04 Million - $2.65 Million	39,600 Added 20.31%	234,565 $14.9 Million
Q1 2021 Apr 23, 2021	BUY	$49.14 - $59.89 $595,822 - $726,166	12,125 Added 6.63%	194,965 $11.7 Million
Q4 2020 Feb 04, 2021	BUY	$42.19 - $51.5 $7.71 Million - $9.42 Million	182,840 New	182,840 $9.13 Million

188

41.3M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Eagle Health Investments LP, based on Form 13F filings with the SEC.

Stay updated on Eagle Health Investments LP with notifications on news.